North America Nuclear Imaging Devices Market – Industry Trends and Forecast to 2029

North America Nuclear Imaging Devices Market, By Technology (Positron Emission Tomography, Single Photon Emission Computed Tomography, Planar Scintigraphy), Application (Oncology, Cardiology, Neurology, Others), End-User (Hospitals, Diagnostic Imaging Centers, Others) – Industry Trends and Forecast to 2029

Market Analysis and Size

Nuclear imaging technologies produce functional and anatomical images of the body, which are used to diagnose a variety of diseases and ailments. These devices operate on the basis of nuclear medicine, which employs the utilization of small amounts of radioactive materials to diagnose and cure for various diseases. Nuclear imaging instruments aid in the early detection of problems, allowing for more prompt therapy. Nuclear imaging technologies are useful because they allow doctors to view into the body without having to do surgery.

Data Bridge Market Research analyses that the nuclear imaging devices market which was USD 2.6 billion in 2021, would rocket up to USD 4.81 billion by 2029, and is expected to undergo a CAGR of 8.0% during the forecast period 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Nuclear imaging devices are medical imaging equipment that use radioactive materials to diagnose the severity of disorders like cardiovascular disease, cancer, gastrointestinal, endocrine, neurological, and other brain problems. These non-invasive devices offer operational data at the molecular and cellular levels, allowing doctors to diagnose and assess medical issues.

Report Scope and Market Segmentation

Nuclear Imaging Devices Market Dynamics

Drivers

•  Growing number of cases with a cardiovascular disorder

The growing geriatric population is one of the major factors driving the nuclear imaging devices market forward. Furthermore, the rising number of cancer patients and research programs and the rise in unhealthy lifestyles and chronic diseases such as diabetes and cardiovascular disorders all contribute to the market's overall growth.

• Technological advancements

Imaging technology improvements have always faced practitioners with a difficulty in identifying how to best use them in patient care, which is projected to drive market expansion.

• Change from standalone to hybrid modalities

In recent years, scientists, researchers, and technicians have integrated systems into clinical practise that combine two or more discrete diagnostic imaging modalities, accelerating the market's growth.

• Upsurge in the incidence of cancer and cardiac ailments

Nuclear medicine holds a lot of promise in the treatment of cancer and heart disease. There are major evidences that using nuclear imaging techniques to diagnose a tumour has a higher influence on patient care in terms of tumour surveillance and treatment response, which contributes to market growth.

Opportunities

Furthermore, the rising need for data-integrated imaging systems is expected to give the nuclear imaging devices market new chances to develop in the future years. The market is likely to benefit from increased investment in diagnostic imaging facilities as well as technological advancements in the field of radiotracers. Advances in radiotracers and the transition from solo to hybrid approaches are likely to boost sales of nuclear imaging systems. Furthermore, demand for nuclear imaging devices is increasing as a result of public-private partnership investments in diagnostic imaging centres and the rising incidence and prevalence of cancer and heart disease.

Restraints/Challenges

On the other hand, the rising cost of diagnostic imaging systems is expected to stifle the nuclear imaging devices market's growth during the forecast period. However, rising hospital budgets may pose a new challenge to the market for nuclear imaging instruments in the near future. Nuclear imaging devices have a few drawbacks in addition to their many benefits. Insurance company lobbying to reduce unnecessary changes, reimbursement legislation, increased payer scrutiny of EMRs, loss of nuclear medicine skills, high instrument costs, supply issues and radiopharmaceutical costs, and the medical device excise tax are all putting a damper on demand for nuclear imaging devices.

This nuclear imaging devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the nuclear imaging devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Nuclear Imaging Devices Market

The COVID-19 outbreak had a substantial influence on the nuclear imaging instrument business. The COVID-19 pandemic has decimated hospital resources all around the world. This has mostly been skilled by drastically lowering in-patient and outpatient care for a wide range of illnesses, as well as instituting infection prevention and control methods. The outbreak afflicted countries all over the world, resulting in a sharp drop in both diagnostic and therapeutic nuclear medicine treatments. The nuclear imaging instruments market, on the other hand, is gradually expanding in demand in the post-COVID situation.

North America Nuclear Imaging Devices Market Scope

The nuclear imaging devices market is segmented on the basis of technique, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technique

• Positron Emission tomography (PET)
• Single-Photon Emission Computed Tomography (SPECT)
• Planar Scintigraphy
• Hybrid Imaging

Application

• Cancer
• Cardiology
• Infection and Inflammation
• Neurology

Nuclear Imaging Devices Market Regional Analysis/Insights

The nuclear imaging devices market is analysed and market size insights and trends are provided by country, technique, application and end-user as referenced above.

The countries covered in the nuclear imaging devices market report are U.S., Canada and Mexico in North America.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The nuclear imaging devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for nuclear imaging devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the nuclear imaging devices market. The data is available for historic period 2010-2020.

Competitive Landscape and Nuclear Imaging Devices Market Share Analysis

The nuclear imaging devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to nuclear imaging devices market.

Some of the major players operating in the nuclear imaging devices market are:

• DIGIRAD CORPORATION (US)
• Neusoft Corporation (China)
• CANON MEDICAL SYSTEMS CORPORATION (Japan)
• SurgicEye GmbH (Germany)
• Mediso Ltd. (US)
• CMR Naviscan. (US)
• DDD-Diagnostic A/S (UK)
• Absolute Imaging Inc. (Canada)
• Bartec Technologies Ltd. (UK)
• BCL X-Ray Canada Inc. (Canada)
• TTG Imaging Solutions, LLC (US)
• Mirion Technologies (Capintec), Inc. (US)
• LANDAUER (US)
• Ashby Gorman Baker Ltd. (UK)
• Lucerno Dynamics, LLC. (US)
• Berthold Technologies GmbH & Co.KG (Germany)
• Incom, Inc. (US), Siemens (US)
• Koninklijke Philips N.V. (Netherlands)
• Spectrum Dynamics Medical (Switzerland)